Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
The deal is a bet on the growing market for psychiatric and neurological drugs.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.